evidencebas
prioriti
set
increasingli
import
ration
distribut
scarc
health
resourc
guid
futur
health
research
use
differ
methodolog
measur
numer
studi
estim
populationlevel
diseas
burden
although
infecti
diseas
regain
promin
highincom
set
recent
outbreak
emerg
reemerg
diseas
sever
acut
respiratori
syndrom
sar
measl
pandem
influenza
comprehens
assess
focus
infecti
diseas
conduct
conduct
ontario
burden
infecti
diseas
studi
onboid
provid
detail
comparison
wide
rang
infecti
diseas
inform
plan
decisionmak
establish
baselin
futur
evalu
public
health
intervent
ethic
approv
obtain
research
ethic
board
sunnybrook
health
scienc
centr
toronto
canada
studi
use
routin
collect
health
inform
provinc
ontario
requir
inform
consent
particip
vital
statist
report
infecti
diseas
data
provid
studi
research
form
aggreg
count
deathsinfect
specif
agesex
strata
hospit
physician
servic
data
use
contain
person
identifi
use
either
aggreg
data
data
without
person
identifi
preclud
need
obtain
inform
consent
addit
institut
clinic
evalu
scienc
ice
name
prescrib
entiti
section
person
health
inform
protect
act
ontario
regul
section
design
ice
receiv
use
health
inform
without
consent
purpos
analysi
compil
statist
inform
health
care
system
ontario
methodolog
onboid
adapt
global
burden
diseas
gbd
popul
health
impact
diseas
canada
studi
studi
use
composit
measur
combin
mortal
morbid
assess
popul
health
prespecifi
ideal
mortal
incid
data
compil
variou
sourc
estim
futur
burden
associ
incid
case
diseas
oneyear
period
includ
infecti
agent
caus
diseas
associ
one
follow
characterist
sever
morbiditymort
high
incid
histor
relev
ie
legal
report
public
health
author
ontario
emerg
interest
eg
new
prevent
program
extens
media
attent
import
pathogen
includ
data
necessari
reliabl
assess
incid
mortal
andor
morbid
avail
ontario
eg
noroviru
rotaviru
h
pylori
also
assess
burden
syndrom
defin
nonspecif
condit
may
caus
differ
pathogen
ontario
canada
popul
provinc
million
resid
year
older
live
urban
area
aborigin
born
outsid
canada
top
five
countri
origin
immigr
china
includ
hong
kong
special
administr
region
unit
kingdom
india
itali
philippin
ontario
estim
approxim
individu
ever
inject
drug
provinci
resid
free
access
hospit
care
essenti
physician
servic
univers
health
insur
quantifi
burden
diseas
use
healthadjust
life
year
hali
hali
composit
measur
gap
ideal
actual
health
incorpor
mortal
morbid
hali
includ
death
occur
prespecifi
maxim
life
expect
ie
year
life
lost
due
prematur
mortal
yll
year
healthi
life
lost
due
suboptim
state
health
associ
diseas
ie
yearequival
reduc
function
due
diseas
yerf
yll
comput
multipli
age
sexspecif
count
death
due
particular
caus
remain
life
expect
age
sex
stratum
sum
across
agesex
strata
obtain
yll
infecti
diseas
infecti
diseas
one
health
state
exampl
health
state
human
immunodefici
viru
hiv
hiv
acquir
immunodefici
syndrom
aid
termin
aid
calcul
yerf
multipli
age
sexspecif
number
incid
case
associ
health
state
averag
durat
health
state
sever
weight
deriv
health
state
sum
yerf
first
agesex
group
across
health
state
obtain
yerf
diseas
detail
provid
support
inform
text
hali
consid
umbrella
term
familiar
qualityadjust
life
year
qali
use
health
econom
disabilityadjust
life
year
dali
use
gbd
studi
calcul
hali
dali
comput
similar
studi
differ
gbd
methodolog
sever
respect
gbd
methodolog
util
standard
life
expect
tabl
coal
demeni
west
level
model
life
tabl
calcul
yll
wherea
use
ontario
life
tabl
gbd
methodolog
disabl
weight
gener
expert
opinion
deriv
sever
weight
health
condit
use
classif
measur
system
function
health
methodolog
yield
comprehens
intern
consist
set
prefer
weight
establish
novel
health
state
gbd
dali
gener
incorpor
ageweight
ie
weight
given
year
lost
young
adulthood
wherea
use
uniform
ageweight
ie
increas
weight
age
group
sinc
ethic
basi
well
calcul
age
weight
highli
contest
gbd
methodolog
discount
futur
life
year
rate
ie
futur
life
year
assign
less
valu
live
today
wherea
discount
life
year
sinc
discount
health
effect
controversi
consensu
appropri
discount
rate
chose
use
gener
hali
diseaseorgan
calcul
threeyear
averag
incid
mortal
use
recent
avail
data
mortal
recent
mortal
data
use
proxi
futur
mortal
result
present
incid
case
mortal
data
use
tenth
revis
intern
classif
diseas
collect
medicallycertifi
death
certif
ontario
offic
registrar
gener
incid
sought
identifi
incid
case
occur
use
data
sever
sourc
obtain
count
report
infecti
diseas
ontario
integr
public
health
inform
system
iphi
possibl
adjust
underdiagnosi
underreport
use
estim
epidemiolog
studi
compar
popul
also
use
epidemiolog
studi
expert
opinion
determin
distribut
health
state
typic
experienc
new
case
diseas
report
case
reflect
incid
case
due
delay
time
infect
symptomat
present
diagnosi
report
hiv
hepat
b
viru
hbv
hepat
c
viru
hcv
use
mathemat
model
gener
accur
estim
diseas
incid
result
health
state
healthcar
util
data
use
estim
incid
infecti
diseas
report
diseas
data
would
suboptim
includ
nonreport
pathogen
pathogen
subset
infect
report
eg
invas
streptococcu
pneumonia
syndrom
etiolog
agent
usual
defin
laboratori
test
data
collect
valid
link
populationbas
databas
data
physician
visit
emerg
depart
visit
hospit
abstract
ontario
health
insur
plan
physician
bill
claim
databas
nation
ambulatori
care
report
system
canadian
institut
health
inform
discharg
abstract
sameday
surgeri
databas
respect
encrypt
health
card
number
use
uniqu
identifi
linkag
individu
across
dataset
gener
healthcar
util
data
use
determin
episod
syndrom
caus
multipl
infecti
agent
eg
pneumonia
case
attribut
variou
pathogen
base
estim
epidemiolog
studi
repeat
healthcar
util
event
patient
consid
repres
singl
episod
infect
occur
within
prespecifi
time
period
tabl
ontario
cancer
registri
ocr
record
case
cancer
except
nonmelanoma
skin
cancer
use
obtain
data
incid
cancer
health
state
select
infecti
diseas
hepatocellular
cancer
hbv
hcv
anogenit
oropharyng
cancer
human
papillomaviru
hpv
illustr
four
main
approach
use
estim
diseas
incid
mortal
present
follow
exampl
pathogen
full
descript
model
use
estim
diseas
burden
avail
technic
report
http
wwwicesoncafileonboidsfullreportintrapdf
salmonella
use
report
diseas
data
adjust
underdiagnosi
underreport
estim
diseas
incid
extract
report
case
salmonellosi
iphi
appli
multipli
adjust
underdiagnosi
underreport
use
epidemiolog
studi
determin
percentag
salmonella
case
experienc
follow
health
state
gastroenter
mild
seek
medic
care
gastroenter
moder
saw
physician
gastroenter
sever
hospit
septicaemia
denomin
ie
adjust
number
case
use
health
state
assum
individu
sever
gastroenter
septicaemia
prior
episod
moder
gastroenter
ie
saw
physician
also
use
epidemiolog
studi
determin
durat
health
state
paramet
present
tabl
mortal
use
vital
statist
data
identifi
death
code
salmonellosi
hiv
use
mathemat
model
use
result
mathemat
model
estim
hiv
incid
extract
hiv
serodiagnos
among
differ
exposur
categori
men
sex
men
inject
drug
use
mothertochild
transmiss
blood
producttransfus
recipi
emigr
endem
area
heterosexu
transmiss
ontario
central
public
health
laboratori
result
detun
assay
use
distinguish
recent
remot
hiv
infect
data
variou
studi
use
adjust
select
bias
associ
hiv
test
pattern
among
individu
vari
risk
hiv
hiv
incid
among
repeat
tester
well
determin
exposur
categori
miss
risk
factor
inform
model
also
produc
estim
aid
incid
use
report
aid
case
ontario
aid
surveil
program
adjust
report
delay
underreport
simplifi
assumpt
case
aid
would
reach
termin
phase
aid
although
possibl
individu
aid
may
die
caus
termin
phase
determin
durat
hiv
aid
use
model
surviv
time
paramet
present
tabl
extract
hivcod
death
vital
statist
data
determin
number
death
due
hiv
hpv
use
cancer
registri
data
epidemiolog
studi
estim
incid
mortal
hpvrelat
cancer
ie
cancer
cervix
vulva
vagina
anal
canal
peni
oropharynx
use
ocr
data
vital
statist
data
respect
appli
epidemiolog
studi
determin
percentag
particular
cancer
attribut
hpv
estim
incid
anogenit
wart
epidemiolog
studi
adapt
approach
develop
statist
canada
estim
burden
cancer
briefli
individu
cancer
experi
follow
health
state
diagnosi
good
fair
poor
prognosi
treatment
surgeri
radiat
chemotherapi
certain
combin
option
remiss
one
treatment
modal
death
occur
within
five
year
palli
care
termin
care
last
month
life
attribut
cancer
obtain
stage
distribut
diagnosi
ie
proport
individu
diagnos
particular
stage
ocr
fiveyear
rel
surviv
estim
treatment
distribut
determin
epidemiolog
studi
expert
opinion
made
sever
simplifi
assumpt
first
incid
case
underw
form
treatment
realiti
patient
frail
diagnosi
receiv
treatment
proport
undergo
treatment
gener
small
second
simplifi
treatment
option
distinguish
cur
palli
radiat
therapi
consid
chemotherapi
associ
mild
moder
sever
toxic
keep
mild
form
third
assum
death
occur
within
five
year
diagnosi
attribut
cancer
ie
surviv
past
five
year
due
anoth
diagnosi
surviv
past
five
year
life
expect
rest
agesex
stratum
fourth
assum
proport
die
within
five
year
independ
type
treatment
die
experienc
averag
year
remiss
five
year
minu
time
spent
palli
five
month
termin
care
one
month
divid
two
year
fifth
assum
reduct
function
similar
remiss
regardless
treatment
modal
modal
employ
final
consid
recurr
cancer
paramet
present
tabl
pneumonia
use
healthcar
util
data
infecti
diseas
syndrom
use
healthcar
util
data
vital
statist
determin
number
episod
death
respect
syndrom
result
pneumonia
infect
bacteri
mening
septicaemia
pneumonia
septic
arthriti
acut
bronchiti
otiti
media
conjunct
also
consid
seizur
motor
deficit
deaf
sequela
bacteri
mening
use
epidemiolog
studi
determin
percentag
syndrom
attribut
pneumonia
estim
death
incid
case
durat
health
state
paramet
present
tabl
calcul
hali
conduct
use
microsoft
excel
worksheet
templat
avail
http
wwwwhointhealthinfoglobalburdendiseasetoolsnationalenindexhtml
conduct
sensit
analysi
estim
burden
top
pathogen
use
gbd
methodolog
gbd
standard
life
expect
disabl
weight
ageweight
discount
rate
total
hali
per
popul
estim
lost
annual
due
infecti
agent
associ
syndrom
studi
year
life
lost
due
prematur
mortal
yll
due
yerf
tabl
modest
correl
yll
yerf
pearson
correl
coeffici
ten
highest
burden
pathogen
hcv
pneumonia
escherichia
coli
hpv
hbv
hiv
staphylococcu
aureu
influenza
viru
clostridium
difficil
rhinoviru
yll
exceed
yerf
pathogen
nearli
burden
attribut
five
pathogen
top
ten
pathogen
account
approxim
total
hali
top
pathogen
account
estim
infecti
diseas
account
death
per
incid
case
per
annual
ontario
tabl
e
coli
pneumonia
hcv
hbv
c
difficil
account
greatest
number
death
rhinoviru
influenza
viru
pneumonia
coronaviru
e
coli
account
greatest
number
incid
case
among
lead
pathogen
overal
burden
compar
sex
howev
observ
number
sexspecif
differ
figur
hcv
hbv
hiv
greater
impact
male
hpv
e
coli
gonorrhea
chlamydia
greater
impact
femal
top
three
select
infecti
diseas
syndrom
pneumonia
septicaemia
urinari
tract
infect
account
total
syndrom
hali
lost
among
syndrom
pneumonia
account
greatest
proport
total
hali
figur
syndrom
yll
account
greater
burden
yerf
except
acut
bronchiti
upper
respiratori
tract
infect
otiti
media
pharyng
conjunct
rank
infecti
diseas
use
gbd
methodolog
gener
similar
spearman
rank
correl
coeffici
gbd
methodolog
indic
greater
proport
burden
attribut
prematur
morbid
versu
mortal
tabl
rank
burden
diseas
associ
infecti
pathogen
syndrom
canadian
provinc
ontario
determin
burden
prematur
mortal
rather
morbid
observ
number
sexspecif
differ
quantifi
burden
syndrom
caus
multipl
pathogen
noteworthi
theme
among
top
ten
includ
pathogen
oncogen
potenti
hcv
hbv
hpv
healthcareassoci
infect
eg
c
difficil
aureu
microorgan
present
normal
human
microbiolog
flora
eg
e
coli
aureu
diseas
prevent
vaccin
hpv
hbv
pneumonia
influenza
viru
notabl
absent
among
top
pathogen
success
prevent
routin
childhood
vaccin
eg
measl
testament
success
program
annual
estim
burden
associ
infecti
diseas
hali
per
popul
close
onequart
hali
per
popul
estim
cancer
combin
canadian
studi
use
similar
methodolog
suggest
infecti
diseas
still
contribut
substanti
morbid
mortal
highincom
set
one
caveat
comparison
burden
hpvrelat
cancer
hepatocellular
carcinoma
includ
studi
rank
infecti
pathogen
rel
consist
pilot
studi
conduct
european
centr
diseas
prevent
control
ecdc
determin
burden
influenza
measl
hiv
tuberculosi
campylobacterosi
salmonellosi
enterohaemorrhag
e
coli
europ
seven
infecti
diseas
rank
similar
order
except
influenza
rank
lower
ecdc
studi
primari
analysi
consid
laboratoryconfirm
case
dramat
underestim
burden
contrast
previou
studi
report
slight
domin
contribut
prematur
mortal
morbid
infect
found
burden
prematur
mortal
discrep
relat
methodolog
differ
calcul
onboid
hali
gbd
dali
use
sever
disabl
weight
discount
ageweight
standard
life
expect
impact
rel
contribut
morbid
versu
prematur
mortal
despit
uncertainti
regard
method
consid
gold
standard
reassur
rank
infecti
diseas
similar
overal
burden
infecti
diseas
compar
male
femal
mark
differ
certain
pathogen
differ
clear
biolog
explan
differenti
burden
hpv
cervic
cancer
femal
e
coli
anatom
differ
result
urinari
tract
infect
femal
differ
hiv
relat
behaviour
ie
anal
intercours
among
men
sex
men
inject
drug
use
preval
among
male
hbv
hcv
differ
may
due
combin
biolog
behaviour
risk
factor
syndromebas
result
guid
priorit
horizont
prevent
method
independ
caus
pathogen
eg
smoke
cessat
hand
hygien
method
prevent
pneumonia
work
need
assess
benefit
possibl
intervent
prevent
syndrom
pathogen
part
analysi
could
address
possibl
cluster
risk
factor
includ
social
determin
health
level
public
concern
media
attent
pathogen
disproportion
actual
diseas
burden
exampl
substanti
media
attent
direct
recent
outbreak
listeria
monocytogen
west
nile
viru
ontario
pathogen
account
small
proport
respect
total
infecti
diseas
burden
contrast
top
pathogen
hcv
hbv
pneumonia
receiv
littl
media
coverag
yet
burdensom
prevent
sinc
media
report
often
influenc
decisionmak
gener
robust
estim
diseas
burden
may
improv
decisionmak
except
linkabl
healthcar
util
data
data
use
studi
readili
avail
highincom
set
studi
like
onboid
could
conduct
mani
jurisdict
similar
data
sourc
adapt
method
paramet
estim
use
onboid
one
major
assumpt
burden
diseas
studi
relationship
incid
mortal
remain
constant
time
may
less
applic
infecti
diseas
incid
sever
frequent
vari
time
also
consid
impact
coinfect
eg
hiv
hcv
comorbid
eg
diabet
influenza
viru
import
synergi
exist
infecti
diseas
notabl
hiv
interact
infecti
diseas
term
natur
histori
transmiss
onboid
comprehens
examin
infecti
diseas
knowledg
studi
exhaust
exclud
certain
pathogen
eg
noroviru
syndrom
eg
surgic
site
infect
health
state
eg
amput
due
seriou
infect
signific
exclus
may
oncogen
pathogen
helicobact
pylori
epsteinbarr
viru
given
find
oncogen
pathogen
among
burdensom
infecti
agent
also
unabl
assess
mani
milder
infect
result
healthcar
util
take
societ
perspect
assess
impact
outbreak
eg
econom
psycholog
import
limit
includ
uncertain
valid
diagnost
code
ascertain
infecti
diseas
assumpt
etiolog
agent
distribut
studi
nonfat
outcom
also
appli
fatal
outcom
relianc
singl
underli
caus
death
may
led
underestim
true
burden
infecti
diseas
eg
death
hasten
precipit
infecti
diseas
would
like
attribut
preexist
condit
miss
burden
undiagnos
infect
final
data
extract
multipl
sourc
vari
qualiti
detail
concern
limit
work
describ
onboid
technic
report
despit
limit
studi
repres
thorough
examin
popul
burden
infecti
diseas
date
result
provid
crude
order
infecti
diseas
use
guid
polici
plan
research
although
data
limit
preclud
greater
level
precis
quantif
uncertainti
result
provid
sens
rel
import
infecti
diseas
studi
less
import
precis
posit
list
fact
top
agent
captur
larg
proport
total
burden
recent
high
profil
infect
absent
next
step
translat
find
inform
tailor
local
decisionmak
gbd
project
signific
impact
global
region
agenc
provinci
analysi
onboid
provid
inform
closer
level
govern
respons
healthcar
policyset
fund
howev
find
like
generaliz
highincom
set
translat
find
polici
decisionmak
must
appreci
herddynam
aspect
infecti
diseas
exampl
fund
highli
success
vaccin
program
divert
toward
highimpact
diseas
identifi
communic
natur
vaccineprevent
diseas
mean
ongo
invest
necessari
maintain
exist
success
also
novel
intervent
eg
new
vaccin
requir
reduc
burden
infecti
diseas
much
burden
alreadi
reduc
improv
implement
exist
intervent
eg
hand
hygien
improv
vaccin
uptak
safe
inject
site
set
prioriti
requir
knowledg
diseas
burden
well
critic
evalu
feasibl
cost
impact
avail
intervent
knowledg
translat
decisionmak
futur
work
assess
econom
broad
societ
burden
associ
infecti
diseas
